Paediatric formulations for the treatment of drug resistant TB: closing the gaps

Affiliations

¹ University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australia, Sydney Institute for Infectious Diseases, University of Sydney, Sydney, NSW, Australia.
² Sydney Institute for Infectious Diseases, University of Sydney, Sydney, NSW, Australia, Children´s Hospital Westmead, Sydney, NSW, Australia.
³ Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, The Netherlands, Department of Pharmaceutical Analysis, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.

Editorial

J W C Alffenaar et al. Int J Tuberc Lung Dis. 2022.

. 2022 Dec 1;26(12):1097-1100.

doi: 10.5588/ijtld.22.0498.

¹ University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australia, Sydney Institute for Infectious Diseases, University of Sydney, Sydney, NSW, Australia.
² Sydney Institute for Infectious Diseases, University of Sydney, Sydney, NSW, Australia, Children´s Hospital Westmead, Sydney, NSW, Australia.
³ Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, The Netherlands, Department of Pharmaceutical Analysis, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.

No abstract available

References

1. World Health Organization Geneva, Switzerland: WHO; 2021. Global Tuberculosis Report, 2021.
1. Dodd PJ, et al. The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health. 2017;5(9):e898–e906. - PMC - PubMed
1. Jenkins HE, et al. Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(3):285–295. - PMC - PubMed
1. World Health Organization Geneva, Switzerland: WHO; 2022. WHO consolidated guidelines on tuberculosis Module 5: Management of tuberculosis in children and adolescents. - PubMed
1. Das M, et al. New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India. Int J Tuberc Lung Dis. 2020;24(12):1265–1271. - PubMed